University of Nottingham

Lipid nanoparticle siRNA antivirals
#Drug delivery #Gene therapy #Lipid based nanoparticle (LNP) #University of Nottingham

New cryogenic ion microscopy used to analyse lipid nanoparticles

Scientists have developed a method for analysing the structure of lipid nanoparticles that could be used to improve vaccine and drug delivery.  A team led by scientists at the University of Nottingham’s School of Pharmacy demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen lipid… Read More

#News

Quantum drug discovery
#Funding #Genetics / genomics #Muscular dystrophy #Quantum computing #University of Nottingham

Funding supports quantum drug discovery for myotonic dystrophy

A team of researchers from the University of Nottingham have received funding to explore the capabilities of quantum computing for developing new drugs for myotonic dystrophy. Building on an initial award of over £1 ($1.3) million, a team of researchers from the University of Nottingham, with… Read More

#News

Orthopaedic surgery
#Drug delivery #Funding #Gene therapy #Innovate UK #TherageniX #University of Nottingham

Innovate UK grant for powdered gene therapy

TherageniX and the University of Nottingham have been awarded a £995,000 ($1,252,585) grant from Innovate UK, the UK’s innovation agency. The funding will support the development of the company’s gene therapy in a powder, a non-viral gene delivery system to improve tissue regeneration following surgery. Read More

#News